» Articles » PMID: 20829802

FFA-induced Adipocyte Inflammation and Insulin Resistance: Involvement of ER Stress and IKKβ Pathways

Overview
Date 2010 Sep 11
PMID 20829802
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Free-fatty acids (FFAs) are well-characterized factor for causing production of inflammatory factors and insulin resistance in adipocytes. Using cultured adipocytes, we demonstrate that FFAs can activate endoplasmic reticulum (ER) stress pathway by examination of ER stress sensor activation and marker gene expression. Chemical chaperone tauroursodeoxycholic acid (TUDCA) can reduce FFA-induced adipocyte inflammation and improve insulin signaling whereas overexpression of spliced X-box protein 1 (XBP-1s) only attenuates FFA-induced inflammation. PKR-like eukaryotic initiation factor 2α kinase (PERK) is one of the three major ER stress sensor proteins and deficiency of PERK alleviates FFA-induced inflammation and insulin resistance. The key downstream target of FFA-induced ER stress is IκB kinase β (IKKβ), a master kinase for regulating expression of inflammatory genes. Deficiency of PERK attenuates FFA-induced activation of IKKβ and deficiency of IKKβ alleviates FFA-induced inflammation and insulin resistance. Consistently, overexpression of IKKβ in 3T3-L1 CAR adipocytes causes inflammation and insulin resistance. In addition, IKKβ overexpression has profound effect on adipocyte lipid metabolism, including inhibition of lipogenesis and promotion of lipolysis. Furthermore, increased endogenous IKKβ expression and activation is also observed in isolated primary adipocytes from mice injected with lipids or fed on high-fat diet (HFD) acutely. These results indicate that ER stress pathway is a key mediator for FFA-induced inflammation and insulin resistance in adipocytes with PERK and IKKβ as the critical signaling components.

Citing Articles

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.


Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.

Abdulla A, Sadida H, Jerobin J, Elfaki I, Mir R, Mirza S J Natl Cancer Cent. 2025; 5(1):8-27.

PMID: 40040878 PMC: 11873641. DOI: 10.1016/j.jncc.2024.11.001.


Interplay of fatty acids, insulin and exercise in vascular health.

Anderson K, Liu J, Liu Z Lipids Health Dis. 2025; 24(1):4.

PMID: 39773723 PMC: 11706162. DOI: 10.1186/s12944-024-02421-5.


Excessive or sustained endoplasmic reticulum stress: one of the culprits of adipocyte dysfunction in obesity.

Jiang Y, Guo J, Wu Y, Zheng P, Wang S, Yang M Ther Adv Endocrinol Metab. 2024; 15:20420188241282707.

PMID: 39381518 PMC: 11459521. DOI: 10.1177/20420188241282707.


Protein Kinases in Obesity, and the Kinase-Targeted Therapy.

Engin A Adv Exp Med Biol. 2024; 1460:199-229.

PMID: 39287853 DOI: 10.1007/978-3-031-63657-8_7.